Back to Directory

Andrea McMunn

Email

andrea.mcmunn@nih.gov

Phone

240-571-1945

Institution

NIH, NIAID, DAIDS, PAB

Address

DAIDS Pharmaceutical Affairs Branch
NIH, NIAID, DAIDS, PAB
5601 Fishers Lane
MSC 9830
Rockville, MD 20892-9829
USA

Request an Update

Affiliated Studies

IMPAACT 2047: Radiant-Moms Plus

DAIDS Number

Research Area

Study Status

IMPAACT 2017: MOCHA

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in People with Hepatitis C with and without HIV

DAIDS Number

Research Area

Study Status

Show All